Skip to Main Content

Trientine Tetrahydrochloride (TETA 4HCL) for the Treatment of Wilson's Disease

Conditions

Diseases of the Nervous System

Phase III

What is the purpose of this trial?

Brief Summary:

This is a multicenter, randomized, open-label study with an active standard-of-care comparator (penicillamine)

  • Trial with
    gmp-orphan SA
  • Start Date
    10/09/2018
  • End Date
    09/29/2019
Trial Image

For more information about this study, contact:

Daksshi Hettiarachchi

I'm interested in volunteering

If you would prefer to contact a member of the Help us Discover team about this trial and other similar trials, please email helpusdiscover@yale.edu or call 877.978.8343

  • Last Updated
    10/11/2018
  • Study HIC
    #2000021684